End-To-End AAV Gene Therapy Solutions

Setting the Standard in AAV Gene Therapy, Together

Adeno-associated virus (AAV) gene therapies have potential to transform the way we treat certain diseases. But to deliver them successfully, robust and cost-effective production is critical.

Bring your therapy to market faster and affordably with end-to-end solutions that deliver reproducible performance and scalability with a simplified path to regulatory approvals.

Consult Our Experts Request Your Sample

Webinar

Inside the Development of an AAV8 Production Platform

Watch our on-demand webinar in collaboration with CDMO Matica Biotechnologies, where we'll showcase a scalable AAV8 production process.   

Watch Now

AAV Gene Therapy Workflow

Solutions for Process Development and Manufacturing

Explore AAV gene therapy solutions to simplify progress in every step of your workflow.

Solutions For AAV Workflow

icon-multiple-choice

Request Your Sample | Raw Materials and Consumables

To help find the right materials and consumables for your needs, request a sample from our portfolio.

Request Your Sample

Featured Products & Services

Accelerate Your Advanced Therapy Development

Optimize your cell and gene therapy process with expert development support—from early stages to scale-up—for efficiency, consistency, and compliance.

Transfection Reagents and pDNA

Increase AAV titer and particle quality with optimized transfection reagents and plasmids. 

HEK293 Media

Generate high yield and titer with scalable and widely compatible media.

Sartoclear® Depth Filters

Remove turbidity, increase AAV yield, and scale up easily with high-capacity and low-adsorption filters. 

Biowelder® TC Sterile Welding Device

Preserve sterility during connection and disconnection throughout your biomanufacturing process.

TFF Cassettes

Increase viral vector recovery using low adsorption membranes with MWCO ranging 30 to 300kDa, available in closed, presterilized units.

Celsius® FFT Freezing Solution

Manage your entire cold chain with confidence – from filling and freezing to shipping, thawing, and dispensing.

Univessel® 2 L Bioreactor

Optimize your therapy for larger volumes with a fully scalable, single-use bioreactor. 

Sartopore® 2 XLG Filter

Achieve a sterile product by using a high-efficiency, low-adsorption, and robust filter to maximize yield.

Flexsafe® 2D Bags

Protect your product during storage and shipping for sterile filtration, media preparation, sampling, and fluid transfer steps.

Ready to Buy?

Browse AAV gene therapy products by searching or filtering by product type.

Shop AAV Gene Therapy Products

AAV R&D Solutions

AAV Research and Development Solutions

Efficient and Compliant AAV Research and Development Solutions

Ensure efficiency, reliability, and scalability from the start with our high-throughput and advanced bioanalytical solutions

FAQs - AAV Gene Therapy

AAV is a small virus less than 30 nm in diameter, containing 5 kb DNA in a capsid with mostly episomal expression. It has different serotypes depending on the capsid's protein expression, supporting targeting of an organ. They are commonly produced using transfection of two to three plasmids to HEK293 — the cells then undergo purification using filtration and chromatogaphy to remove impurities.

Read Now

Critical Quality Attributes (CQAs) are typically established during a risk assessment and depend on the specific drug being developed. For most drugs, the focus includes product safety, identity, sterility, purity, and potency. In the case of Adeno-Associated Virus (AAV) therapies, measuring potency is challenging. Potency assessments can involve evaluating genomic and capsid titers, as well as transduction efficiency. Ensuring purity is also crucial to avoid side effects; therefore, monitoring impurities such as empty AAV particles, DNA, and protein content is essential.

To increase performance of AAV processes, we offer HEK media and transfection reagents like FectoVIR®-AAV and pPLUS® AAV-Helper. Combined with single-use bioreactors offering the same geometry from 250 mL to 2000 L, we ensure a simplified scale-up.
We also offer solutions for clarification like Sartoclear® depth filters, Hydrosart® cassettes, Sartopore® 2 XLG sterilizing filter, and monolith columns that are scalable from process development to large-scale manufacturing — in single-use and closed formats.

Downstream processes should remove impurities like DNA and HCP to maximize drug safety and efficacy. In AAV production, separating the large amount of empty capsids — up to 80% — is challenging due to their similarity to full capsids. AAV concentration can also cause aggregation and loss due to binding to filter materials, resulting in low overall performance.

At Sartorius, we offer solutions like Sartoclear® depth filters, Hydrosart® cassettes for TFF with low-binding filters, and monolith technology with QA to efficiently remove impurities and empty capsids. Additionally, Recombumin® recombinant human albumin prevents AAV aggregation.

Related Pages

Browse additional products, services, and training for AAV gene therapy.

CIMmultus® Monolithic Chromatographic Columns

Purify AAV vectors with convective chromatography columns that enable effective empty full capsid separation.

Validation Services | Compliance with Regulatory Requirements

Address regulatory challenges with validation services trusted by the biopharmaceutical industry.

Plasmid DNA (pDNA) Production

Discover solutions for every step of plasmid DNA manufacturing, from bacteria to final filtration.

More About AAV Gene Therapy From Sartorius

Sartorius Event

Virtual Event | AAV — Stirred, Not Shaken

Get a taste of the latest developments in AAV gene therapy manufacturing and stir things up with a mocktail-making session. 

Watch Now

Related Assets

Webinar

Next Generation of Genetic Engineered AAV Helper Plasmids

Discover how next-generation helper plasmids can boost rAAV productivity and quality with insights from Sartorius and DiNAMIQS.

Webinar

Building an AAV Platform: Challenges, Threats and Opportunities

Showcasing how Sartorius Polyplus and ABL implemented a comprehensive DoE strategy with a platform approach.

Webinar

Enabling a Robust AAV Upstream Platform Using Next-Gen Raw Materials

In collaboration with Nantes University, this webinar will demonstrate an upstream AAV platform made with a DOE approach.

Webinar

Support high-performing, scalable AAV purification

Watch our webinar with iBET and learn how to establish a scalable platform for multiple AAV serotypes from PD to manufacturing.

Poster

Using High-Throughput and DoE Tools to Develop DSP Technology for AAV

Learn how an optimized DSP platform can improve process development timelines and manufacturing complexity in AAV gene therapy.

Application Note

How Filters Can Optimize Your AAV Clarification

This study demonstrates the suitability and competitiveness of Sartoclear® depth filters for the clarification step in suspension-based AAV processes.

Automated High-Throughput AAV TFF Process Development

Read about a high-throughput method for developing AAV tangential flow filtration (TFF) processes, essential for gene therapy production.

White Paper

Navigating Upstream AAV Production for Gene Therapy Manufacturing

Your checklist from research and development to clinical and commercial production.

Article

Switching from Bottles to Bags: Robust by Design

Weigh the pros and cons of bottles and single-use bags with help from our experts.

Webinar

Screen, Optimize, and Characterize Your Viral Vector Production

Learn early PD strategies that enhance clinical-stage production of AAV and LV.

Octet® AAVX Biosensors for Rapid and Direct Quantitation of AAV Capsids
Application Note

Rapid and Direct Quantitation of AAV Capsids

Learn about a workflow for rapid, direct, and label-free quantitation of AAV capsids in crude and purified samples.

Application Note

The Journey to AAV Production in Suspension: Scaling-Up Your Process

See how using suspension HEK cultures can make your scale-up more robust.

AAV Gene Therapy Courses From Sartorius Academy

Training

Upstream Viral Vector Processing

Get insight on market trends, needs, and challenges related to AAV, LV, and AdV upstream processing.

Training

Downstream Viral Vector Processing

Learn more about viral vector purification including chromatography, filtration, and more, along with analytics and market trends.

icon-contact-us

Stay Up-to-Date

Sign up for our newsletter to get updates on the latest solutions for AAV and LV gene therapy.

Sign Up for Newsletter

Consult Our Experts

Consult Our Cell and Gene Therapy Experts